One-sentence summary of key findings: SOBR Safe, Inc. is a small, highly volatile microcap technology company focused on non-invasive transdermal alcohol detection devices that faces severe financial distress, has announced plans to wind down its core operations by July 31, 2026, and is pursuing a proposed business combination with Clean World Ventures amid limited analyst coverage and ongoing restructuring.
Fact: The stock has exhibited extreme volatility typical of microcap names, with a 52-week trading range of approximately $0.35 to $4.50.[Yahoo Finance]
Interpretation: Such wide swings are often driven by news events like merger announcements, warrant exercises, and operational restructuring rather than fundamental business performance.
Uncertainty: Long-term performance has been poor, with reports indicating substantial declines over 1-year and multi-year periods, likely influenced by dilution, reverse stock splits, and low liquidity.
Data Limitation: Historical performance data is subject to reverse splits and corporate actions; past results are not indicative of future performance. All data drawn from public filings and market reports as of mid-July 2026.
Fact: Trailing twelve months (TTM) revenue stands at approximately $430,000, with a reported gross margin around 54% on this minimal base.[Yahoo Finance / StockTitan]
| Metric (TTM / Recent) | Value | Notes |
|---|---|---|
| Revenue (TTM) | ~$430K | Primarily from product sales and services |
| Net Income (TTM) | ~-$9.0M to -$9.36M | Significant operating losses |
| EPS (Diluted, TTM) | ~-5.58 to -6.12 | Reflects heavy dilution and losses |
| Cash (Most Recent Quarter) | ~$2.12M | Boosted by recent financings |
| Debt/Equity (MRQ) | ~3.79% | Low leverage |
| Operating Cash Flow (TTM) | Negative (~-$7M range in reports) | High cash burn |
| Return on Assets / Equity | -68.74% / -131.91% | Deeply unprofitable |
Fact: Q1 2026 results showed revenue of $79K with continued substantial losses.[IR Site]
Interpretation: The company operates with minimal revenue scale relative to its cost structure, indicating a pre-commercial or early-stage business model reliant on external financing.
Uncertainty: Future financial trajectory depends heavily on the outcome of the proposed merger and wind-down plans; recent warrant exercises provided ~$3.1M gross proceeds (July 2026), and a prior $2M private placement closed in late 2025.
Data Limitation / Assumption: Financial figures are based on latest available SEC filings and aggregator reports (e.g., 10-Q/10-K summaries as of Q1 2026 and FY 2025); exact quarterly breakdowns may require direct 10-Q review. Small revenue base makes margins sensitive to any single sale.
Fact: Analyst coverage is extremely limited for this microcap stock.[MarketBeat]
| Source | Rating / Consensus | Details |
|---|---|---|
| MarketBeat (aggregated) | Sell | Based on 1 analyst rating in the last 12 months |
| Weiss Ratings | Sell (E+ or similar) | Recent upgrade/downgrade noted in reports |
| IR-listed firms (e.g., Diamond Equity, Zacks, Goldman Small Cap) | Coverage exists but specific current ratings not detailed in public summaries | Primarily small-cap research providers |
Interpretation: The "Sell" consensus reflects concerns over financial viability, low revenue, and operational uncertainties rather than growth prospects.
Uncertainty: With only one or very few active ratings, consensus may not represent broad Wall Street views; many microcaps have no formal coverage.
Data Limitation: Analyst ratings and price targets (none prominently available) change frequently and are not investment advice. Check latest filings or platforms like Yahoo Finance / MarketBeat for updates.
Fact: Targeted and reported users include judicial/reentry centers (e.g., historical adoption by Alternatives, Inc. for residential programs replacing traditional breathalyzers), potential applications in commercial trucking, teen driver monitoring, outpatient alcohol treatment, co-parenting accountability, workplaces, families, and organizations seeking wellness/behavioral tools.[IR Press Releases]
Interpretation: The customer base appears niche and relationship-driven, with emphasis on safety-sensitive sectors, though scale remains small given revenue levels.
Uncertainty: Impact of the July 2026 decision to discontinue alcohol monitoring operations (SOBRcheck, SOBRsure, and related software/services effective July 31, 2026) on existing or prospective customers is unclear and likely disruptive.
Fact: Direct competitors in transdermal or passive alcohol detection are limited; broader market includes traditional breathalyzer manufacturers (e.g., NHTSA-approved devices from Alco Check International, Alcolizer, Alcohol Countermeasure Systems, and others) and continuous monitoring solutions like SCRAM ankle bracelets or ignition interlock providers (e.g., Smart Start, Draeger).[NHTSA Lists] [Company Materials]
| Category | Examples | Key Differentiator vs. SOBR |
|---|---|---|
| Traditional Breathalyzers | Alco Check, Intoximeters, etc. | Invasive (breath sample required) |
| Continuous Wearables | SCRAM Systems (ankle monitors) | Typically more invasive or different form factor |
| Ignition Interlock / Fleet | Smart Start, Draeger | Often vehicle-integrated; SOBR emphasizes touch/passive |
Interpretation: SOBR positions its technology as hygienic and non-invasive (no breath/blood/urine), potentially offering advantages in wellness and certain access-control scenarios, though commercialization has been challenging.
Uncertainty: With the planned wind-down of core operations, competitive positioning may become moot; merger with Clean World Ventures could shift the business entirely.
Data Limitation: Competitor information is inferred from industry context and company positioning; no comprehensive independent competitive analysis available in searches. Customer details are primarily from historical press releases and may not reflect current status post-restructuring announcements.
Fact: Develops transdermal (touch-based) sensing technologies combining hardware and cloud software for alcohol detection and awareness. Key products historically: SOBRcheck (stationary touch device, launched ~2021) and SOBRsure (wearable wristband, launched ~2023).[Official IR]
Fact: Founded references vary (2004 in some sources like Yahoo; emphasis on 2020 re-focus or rebranding in IR materials); headquartered in Greenwood Village, Colorado (Denver area); ~18 employees; CEO David J. Gandini.[Yahoo Finance]
Interpretation: The company has pivoted toward wellness and behavioral applications beyond traditional enforcement uses.
Uncertainty: Recent events (April 2026 merger proposal with Clean World Ventures where CWV holders reportedly to own majority of combined entity; July 2026 wind-down approval and warrant financing) introduce significant strategic uncertainty.
Links for More Information: